Seed capital
Building the future through novel therapies, medical devices and deep engineering, take time. We’re willing to stay the course.
Human Health and the Physical World.
At Stoic, we know that breakthrough innovation is found in all domains of research. We come in early, looking to partner with founders at early TRL levels.
We write first cheques between $100k to $500k.
High tech capital.
Our mission is to bring catalytic technologies to market, to solve what was previously unsolvable.
Tracking TRLs over time is one way we visualise value creation and retiring technical risk as investors.
Conviction-first investing.
We believe that having a strong conviction, immersion and patience is more valuable than any accreditation.
Our founding partners have decades of experience raising capital and investing in companies from therapeutics to satellite technologies.
Collaborative venture.
In 2019 we were founded on a partnership with Uniseed – Australia’s longest standing venture fund.
Since then, we’ve built a proprietary funnel & network of Investors, Operators and Academics who have lived through it all.
Whenever you’ve got a question, we’ve got the right people ready to chat.
What we bring to the table.
Small team, big ambition
We’re lean but locked in. We’re proud of our efficiency and ambitious of our partnerships.
Commercial and financial expertise
We leverage our unique DNA from diverse backgrounds to help you from lab-to-market.
Highlights
22x
investments
4x
exits
5x
female founders
5x
sectors
Our Founders
Having investors like Stoic with expertise that complements or fills gaps, as well as a genuine interest and shared passion for helping achieving outcomes, has been rewarding for everyone involved and contributed to our growth
Geoff has been greatly supportive and generous with his time. From new connections that have allowed us to grow, to unbiased opinion & guidance whenever I need it most. We are lucky to have Geoff on the journey.
